Concepedia

Publication | Open Access

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

160

Citations

34

References

2007

Year

Abstract

Intranasal PYY(3-36) as administered at these intervention doses and preprandial timing is not efficacious in inducing weight loss in obese patients after 12 wk of treatment.

References

YearCitations

2002

2.3K

2003

1.6K

2002

1.3K

1985

1.1K

2005

978

1980

655

2005

541

2002

429

2005

419

2005

419

Page 1